ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, B
Right arrow Articles by Robertson, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, B
Right arrow Articles by Robertson, B
Eur Respir J 1997; 10: 1967-1974
Copyright © ERS Journals Ltd 1997


Original Articles

Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A

B Sun, T Curstedt, G Lindgren, B Franzen, AA Alaiya, A Calkovska, and B Robertson

Surfactant protein A (SP-A), a major protein component of natural pulmonary surfactant, is absent in exogenous surfactants currently used in clinical practice. We investigated the physical and physiological properties of one of these modified natural surfactants (Curosurf) after enrichment with 5% SP-A (SP-A-Curosurf). A pulsating bubble system was used for in vitro assessments and ventilated newborn rabbits for evaluation of in vivo effects. In the presence of various potential inhibitors (meconium 5 mg.mL-1, fibrinogen 5 mg.mL-1, albumin 25 mg.mL-1, or whole serum proteins 25 mg.mL-1), Curosurf at a concentration of 5 mg.mL-1 was inactivated while SP-A-Curosurf and natural porcine surfactant at the same concentration had normal maximum and minimum surface tension. This protective effect of SP-A was calcium dependent. In immature newborn rabbits, the improvement of lung-thorax compliance observed after treatment with 100 mg.kg-1 of SP-A-Curosurf was equivalent to that obtained with 200 mg.kg-1 of Curosurf. Similarly, in near-term newborn rabbits with respiratory failure induced by instillation of fibrinogen via the airways, the increase in compliance after administration of 100 mg.kg-1 of SP-A-Curosurf corresponded to that seen after treatment with 200 mg.kg-1 of Curosurf, whereas Curosurf at a dose of 100 mg.kg-1 had no substantial effect. Our data thus indicate that surfactant protein A increases the resistance of Curosurf to inactivation under in vivo conditions.


This article has been cited by other articles:


Home page
Biophys. JHome page
Y. Y. Zuo, S. M. Tadayyon, E. Keating, L. Zhao, R. A. W. Veldhuizen, N. O. Petersen, M. W. Amrein, and F. Possmayer
Atomic Force Microscopy Studies of Functional and Dysfunctional Pulmonary Surfactant Films, II: Albumin-Inhibited Pulmonary Surfactant Films and the Effect of SP-A
Biophys. J., September 15, 2008; 95(6): 2779 - 2791.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
Y. Y. Zuo, E. Keating, L. Zhao, S. M. Tadayyon, R. A. W. Veldhuizen, N. O. Petersen, and F. Possmayer
Atomic Force Microscopy Studies of Functional and Dysfunctional Pulmonary Surfactant Films. I. Micro- and Nanostructures of Functional Pulmonary Surfactant Films and the Effect of SP-A
Biophys. J., May 1, 2008; 94(9): 3549 - 3564.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
A. Saenz, O. Canadas, L. A. Bagatolli, F. Sanchez-Barbero, M. E. Johnson, and C. Casals
Effect of Surfactant Protein A on the Physical Properties and Surface Activity of KL4-Surfactant
Biophys. J., January 15, 2007; 92(2): 482 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Xu, T. Kobayashi, X. Cui, K. Ohta, C. Kabata, and K. Tashiro
Lung volumes and alveolar expansion pattern in immature rabbits treated with serum-diluted surfactant
J Appl Physiol, October 1, 2004; 97(4): 1408 - 1413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. M. BRACKENBURY, P. S. PULIGANDLA, L. A. McCAIG, V. NIKORE, L.-J. YAO, R. A. W. VELDHUIZEN, and J. F. LEWIS
Evaluation of Exogenous Surfactant in HCl-induced Lung Injury
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1135 - 1142.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. ALMAAS, B. ROBERTSON, B. LINDERHOLM, E. LUNDBERG, O. D. SAUGSTAD, and A. MOEN
Reversal of Meconium Inhibition of Pulmonary Surfactant by Ferric Chloride, Copper Chloride, and Acetic Acid
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1789 - 1794.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
M. van Eijk, H. P. Haagsman, T. Skinner, A. Archibold, K. B. M. Reid, and P. R. Lawson
Porcine Lung Surfactant Protein D: Complementary DNA Cloning, Chromosomal Localization, and Tissue Distribution
J. Immunol., February 1, 2000; 164(3): 1442 - 1450.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. Kobayashi, K. Ohta, K. Tashiro, K. Nishizuka, W.-M. Chen, S. Ohmura, and K. Yamamoto
Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract
J Appl Physiol, June 1, 1999; 86(6): 1778 - 1784.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the European Respiratory Society.